Patent · US Expired

Neospora vaccine

US6787146B2 · kind B2 · utility

3Cited by
2References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 9, 2001
Grant dateSep 7, 2004
Priority date
Expiry dateNov 9, 2021

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides an homogenate prepared from cells of Neospora, and vaccines against neosporosis prepared therefrom which are useful in the prevention of clinical disease and abortion in mammals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.